Center for Advanced Technology awards support Cornell life science faculty and research associates to develop biotechnologies with commercial potential.
A new Weill Cornell Medical College study finds treating terminal late-stage cancer patients with chemotherapy does not improve quality of life and are of no benefit to overall survival.
Twenty-two architecture and urban design professionals from China took part in the College of Architecture, Art and Planning’s first international executive education program.
Lung cancers attract circulating immune cells to the tumor mass, where the cancer reprograms them to support its growth and progression, researchers from Weill Cornell Medical College have found.
Patients who develop bacterial endocarditis have an elevated risk of stroke beginning four months before, and up to five months after diagnosis – a period significantly longer than previously reported.
Weill Cornell Medical College researchers have found that if PTEN, a known tumor-suppressor gene, has mutated or is absent, the DNA replication process derails and can lead to cancer development.
A noninvasive scan that determines the extent of plaque buildup in the heart predicts the likelihood of heart attack or death over a 15-year period, according to a Weill Cornell Medical College research team.
Weill Cornell Medical College investigators have discovered the precise molecular steps that enable immune cells implicated in certain forms of asthma and allergy to develop and survive in the body.
Weill Cornell Medical College researchers have found that the order in which obese patients with type 2 diabetes eat food matters and may help control glucose levels.
